Pages that link to "Q39502863"
Jump to navigation
Jump to search
The following pages link to Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children. (Q39502863):
Displaying 5 items.
- The extent of intestinal failure-associated liver disease in patients referred for intestinal rehabilitation is associated with increased mortality: an analysis of the pediatric intestinal failure consortium database (Q47931672) (← links)
- Effect of a fish oil-based lipid emulsion on intestinal failure-associated liver disease in children (Q49570743) (← links)
- Pediatric Intestinal Failure-Associated Liver Disease: Challenges in Identifying Clinically Relevant Biomarkers (Q50005577) (← links)
- Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil (Q58584750) (← links)
- Rifampicin, not vitamin E, suppresses parenteral nutrition-associated liver disease development through the pregnane X receptor pathway in piglets (Q90656773) (← links)